利用多种调节的细胞死亡模式来识别阿尔茨海默病的诊断生物标志物
1Dr Xueyan Chen, Beijing Key Laboratory of Mental Disorders, National Clinical Research Center for Mental Disorders and National Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China, Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China,
The journal of prevention of Alzheimer's disease
|November 19, 2024
概括
在阿尔茨海默病 (AD) 中确定了受调细胞死亡 (RCD) 亚型,导致RCD.score. 这一分数有效地预测了AD的进展,并有助于个性化治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 调节细胞死亡 (RCD) 功能与阿尔茨海默病 (AD) 有关.
- 有限的研究存在于RCD相关基因在AD的诊断和免疫作用.
- 需要进行系统的研究,以了解RCD对AD的影响.
研究的目的:
- 根据与RCD相关的基因识别AD的不同亚型.
- 使用RCD相关基因开发AD进展的预测模型.
- 探索阿尔茨海默病亚型的免疫学景观和治疗影响.
主要方法:
- 对8个多中心AD队列的分析合并为一个元队列.
- 无监督的集群定义基于RCD基因的AD亚型.
- 不同基因表达 (DEGs),权重基因相关性网络分析 (WGCNA) 和用于RCD的机器学习.
主要成果:
- 确定了两种独特的AD亚型,具有独特的途径活性和免疫特征.
- 开发了一个RCD.score,证明了AD进展的强大预测能力.
- 高RCD.score组显示免疫透和信号通路激活增加,与AD进展不佳相关.
- 四个关键基因 (CXCL1,ENTPD2,METTL7A,SERPINB6) 被确定为AD特征.
结论:
- RCD模型有效地对AD患者进行了分类.
- 该RCD.score作为一个有价值的工具来预测AD的进展.
- 这个模型可以为阿兹海默症患者指导个性化治疗计划.
相关概念视频
01:26Alzheimer's Disease: Overview
448
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
01:30Dementia
97
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
97
01:22Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165